What Is Neurokinin A? Definition and What Research Reports

Definition

Neurokinin A (NKA), historically also called substance K or neuromedin L, is a ten-amino-acid tachykinin — a small signalling peptide that ends in the conserved C-terminal motif Phe-X-Gly-Leu-Met-amide shared across the tachykinin family. It is generated by processing of the preprotachykinin-A precursor encoded by the TAC1 gene, the same precursor that yields substance P, which is why the two peptides are so often measured and tested side by side. Neurokinin A binds all three mammalian tachykinin receptors but shows preference for the NK₂ receptor, whereas substance P is the preferred ligand at NK₁ and neurokinin B (a separate gene product, TAC3) at NK₃. In tissue, neurokinin A is associated with sensory nerve fibres and with smooth-muscle-rich organs including the gut, airways and urogenital tract. This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question.

Where the Molecule Comes From

Because neurokinin A and substance P arise from a single precursor transcript, tissues that express TAC1 typically release both. Extended forms of the same precursor (neuropeptide K and neuropeptide gamma) contain the neurokinin A sequence at their C-terminus. Once released, tachykinins are short-lived: they are broken down by peptidases, and researchers have shown that even microbial enzymes can cleave them — one 2019 report described surface-associated proteases of Mycoplasma hyopneumoniae cleaving bradykinin, substance P, neurokinin A and neuropeptide Y in vitro. Chemical stability has been examined separately: a 2010 inorganic biochemistry study characterised the metal-coordination behaviour of neurokinin A and a derivative and the products formed after metal-catalysed oxidation of the peptide.

How the Term Is Used in Peptide Research

Across the published record, "neurokinin A" appears in three broad roles:

• As an analyte or biomarker. Concentrations are measured in plasma, sputum, saliva, gingival crevicular fluid, dental pulp or brain tissue and compared between defined groups.
• As a pharmacological agonist. The synthetic peptide is applied to isolated organs or perfused tissue to probe NK₂-receptor-mediated responses such as smooth-muscle contraction or hormone release.
• As a biochemical substrate. The sequence is used in enzymology, oxidation and metal-binding experiments.

Research contexts at a glance

What the Published Literature Reports

Measurement in human samples

A 2023 review in Neonatal Network examined the role of substance P, neurokinin A, neuropeptide Y and cortisol in assessing neonatal pain, treating the peptides as candidate objective markers alongside behavioural scoring. In dentistry, a 2017 comparative study measured substance P and neurokinin A in gingival crevicular fluid from healthy teeth and from painful carious permanent teeth, and a 2020 study in the Journal of Endodontics compared neurokinin A, substance P, interleukin 8 and matrix metalloproteinase-8 in pulp tissue and gingival crevicular fluid from healthy teeth and teeth with symptomatic irreversible pulpitis. In respiratory research, a 2008 study measured sputum neurokinin A in Egyptian asthmatic children and adolescents and related the values to exacerbation severity.

Measurement itself has been the subject of methodological work: a 2011 paper in Pancreas reported on the validation of neurokinin A assays in use in the United States and Europe, a reminder that reported concentrations depend heavily on the assay platform used.

Animal and isolated-tissue experiments

Where neurokinin A is applied rather than merely measured, the work has been in animals or excised tissue. A 2022 study in International Journal of Molecular Sciences examined the effects of substance P and neurokinin A on the contractile activity of inflamed porcine uterus. In neuroendocrinology, a 2020 study investigated neurokinin A and its receptor in the regulation of prolactin secretion by the anterior pituitary of cyclic pigs, while a 2016 Endocrinology paper asked whether substance P and neurokinin A play important roles in the control of LH secretion in ewes. Central-nervous-system work includes a 2022 study in which neuropeptide Y, calcitonin gene-related peptide and neurokinin A levels across brain regions of high-anxiety-behaviour rats were correlated with anxiety-like behaviours, and a 2010 report on secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina.

Biochemistry and degradation

The peptide's fate outside the receptor has also been studied. Researchers reported that surface-associated proteases from Mycoplasma hyopneumoniae cleaved bradykinin, substance P, neurokinin A and neuropeptide Y in a 2019 Scientific Reports paper, and a 2010 study characterised the coordination abilities of neurokinin A and its derivative together with the products of metal-catalysed oxidation. Both lines of work bear on why intact tachykinin measurements are technically demanding.

Safety and Adverse Events: What Studies Report

The verified literature gathered here is made up of measurement studies in humans, experiments in animals and isolated tissues, and biochemical work; none of these papers was designed as a human safety or tolerability trial of administered neurokinin A, and none reported adverse-event data in people receiving the peptide. The human-facing entries are observational: the 2023 neonatal review discussed the peptide as a pain-assessment marker rather than as something given, the 2020 endodontic study sampled pulp tissue and crevicular fluid from existing clinical conditions without administering peptide, and the 2008 asthma study measured sputum concentrations already present in participants' airways. Where neurokinin A was actually applied, it was applied to excised porcine uterine tissue in an organ-bath setting rather than to human subjects, and to livestock in neuroendocrine experiments such as the ewe LH study reported in 2016. No dosing information for humans can be drawn from any of these sources.

Points of Confusion

• Neurokinin A vs. substance P: different peptides from the same TAC1 precursor, with different receptor preferences; they are frequently measured together, as in the dental and neonatal work cited above.
• Neurokinin A vs. neurokinin B: neurokinin B is a distinct TAC3 gene product with NK₃ preference and its own reproductive-neuroendocrine literature.
• Neurokinin A vs. NK-receptor antagonists: approved antiemetic drugs act at the NK₁ receptor and are pharmaceuticals, not the endogenous peptide described here.
• Assay values are not interchangeable: as the validation work in Pancreas indicated, results depend on the method used.

References

• The Role of Substance P, Neurokinin A, Neuropeptide Y, and Cortisol in Assessing Neonatal Pain (Neonatal Network, 2023)
• Effects of Substance P and Neurokinin A on the Contractile Activity of Inflamed Porcine Uterus (International Journal of Molecular Sciences, 2022)
• The role of neurokinin A and its receptor in the regulation of prolactin secretion by the anterior pituitary of cyclic pigs (Reproduction in Domestic Animals, 2020)
• Validation of neurokinin A assays in the United States and Europe (Pancreas, 2011)
• Do Substance P and Neurokinin A Play Important Roles in the Control of LH Secretion in Ewes? (Endocrinology, 2016)
• Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours (European Neuropsychopharmacology, 2022)
• Mycoplasma hyopneumoniae surface-associated proteases cleave bradykinin, substance P, neurokinin A and neuropeptide Y (Scientific Reports, 2019)
• Coordination abilities of neurokinin A and its derivative and products of metal-catalyzed oxidation (Journal of Inorganic Biochemistry, 2010)
• Comparative study of substance P and neurokinin A in gingival crevicular fluid of healthy and painful carious permanent teeth (Dental Research Journal, 2017)
• Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina (Regulatory Peptides, 2010)
• Sputum neurokinin A in Egyptian asthmatic children and adolescents: relation to exacerbation severity (Allergy, 2008)
• Comparison of Neurokinin A, Substance P, Interleukin 8, and Matrix Metalloproteinase-8 Changes in Pulp Tissue and Gingival Crevicular Fluid Samples of Healthy and Symptomatic Irreversible Pulpitis Teeth (Journal of Endodontics, 2020)